These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22980768)

  • 1. TREAT-NMD workshop: pattern recognition in genetic muscle diseases using muscle MRI: 25-26 February 2011, Rome, Italy.
    Straub V; Carlier PG; Mercuri E
    Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S42-53. PubMed ID: 22980768
    [No Abstract]   [Full Text] [Related]  

  • 2. Whole body muscle MRI protocol: pattern recognition in early onset NM disorders.
    Quijano-Roy S; Avila-Smirnow D; Carlier RY;
    Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S68-84. PubMed ID: 22980770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards harmonization of protocols for MRI outcome measures in skeletal muscle studies: consensus recommendations from two TREAT-NMD NMR workshops, 2 May 2010, Stockholm, Sweden, 1-2 October 2009, Paris, France.
    Hollingsworth KG; de Sousa PL; Straub V; Carlier PG
    Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S54-67. PubMed ID: 22980769
    [No Abstract]   [Full Text] [Related]  

  • 4. Whole-body muscle magnetic resonance imaging in SEPN1-related myopathy shows a homogeneous and recognizable pattern.
    Hankiewicz K; Carlier RY; Lazaro L; Linzoain J; Barnerias C; Gómez-Andrés D; Avila-Smirnow D; Ferreiro A; Estournet B; Guicheney P; Germain DP; Richard P; Bulacio S; Mompoint D; Quijano-Roy S
    Muscle Nerve; 2015 Nov; 52(5):728-35. PubMed ID: 25808192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
    Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
    Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locomotor system assessment by muscle magnetic resonance imaging.
    Fleckenstein JL; Weatherall PT; Bertocci LA; Ezaki M; Haller RG; Greenlee R; Bryan WW; Peshock RM
    Magn Reson Q; 1991 Apr; 7(2):79-103. PubMed ID: 1911234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Magnetic resonance tomography in generalized skeletal muscle diseases. Examination modalities and indications recommendations].
    Kaiser WA; Schalke BC
    Rontgenpraxis; 1989 Oct; 42(10):338-45. PubMed ID: 2814682
    [No Abstract]   [Full Text] [Related]  

  • 8. Magnetic resonance imaging of skeletal muscle.
    Koltzenburg M; Yousry T
    Curr Opin Neurol; 2007 Oct; 20(5):595-9. PubMed ID: 17885451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of MRI in muscle diseases.
    Carlier PG; Mercuri E; Straub V
    Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S41. PubMed ID: 22980767
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnetic resonance imaging of muscle disease: a pattern-based approach.
    Costa AF; Di Primio GA; Schweitzer ME
    Muscle Nerve; 2012 Oct; 46(4):465-81. PubMed ID: 22987686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle magnetic resonance imaging: a new diagnostic tool with promising avenues in therapeutic trials.
    Quijano-Roy S; Carlier RY
    Neuropediatrics; 2014 Oct; 45(5):273-4. PubMed ID: 25184740
    [No Abstract]   [Full Text] [Related]  

  • 12. A new phenotype of dysferlinopathy with congenital onset.
    Paradas C; González-Quereda L; De Luna N; Gallardo E; García-Consuegra I; Gómez H; Cabello A; Illa I; Gallano P
    Neuromuscul Disord; 2009 Jan; 19(1):21-5. PubMed ID: 19084402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-Body muscle MRI in a series of patients with congenital myopathy related to TPM2 gene mutations.
    Jarraya M; Quijano-Roy S; Monnier N; Béhin A; Avila-Smirnov D; Romero NB; Allamand V; Richard P; Barois A; May A; Estournet B; Mercuri E; Carlier PG; Carlier RY
    Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S137-47. PubMed ID: 22980765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hreditary myopathies].
    Kuhn E
    Ergeb Inn Med Kinderheilkd; 1969; 28():188-290. PubMed ID: 4897097
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnetic resonance imaging in the idiopathic inflammatory myopathies.
    Fraser DD; Frank JA; Dalakas M; Miller FW; Hicks JE; Plotz P
    J Rheumatol; 1991 Nov; 18(11):1693-700. PubMed ID: 1787491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel FHL1 mutations in fatal and benign reducing body myopathy.
    Shalaby S; Hayashi YK; Nonaka I; Noguchi S; Nishino I
    Neurology; 2009 Jan; 72(4):375-6. PubMed ID: 19171836
    [No Abstract]   [Full Text] [Related]  

  • 17. Consequences of mutations within the C terminus of the FHL1 gene.
    Schoser B; Goebel HH; Janisch I; Quasthoff S; Rother J; Bergmann M; Müller-Felber W; Windpassinger C
    Neurology; 2009 Aug; 73(7):543-51. PubMed ID: 19687455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle physiology and pathophysiology: magnetic resonance imaging evaluation.
    Shellock FG; Fleckenstein JL
    Semin Musculoskelet Radiol; 2000; 4(4):459-79. PubMed ID: 11371329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy.
    Mercuri E; Lampe A; Allsop J; Knight R; Pane M; Kinali M; Bonnemann C; Flanigan K; Lapini I; Bushby K; Pepe G; Muntoni F
    Neuromuscul Disord; 2005 Apr; 15(4):303-10. PubMed ID: 15792870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The appearance of the piriformis muscle syndrome in computed tomography and magnetic resonance imaging. A case report and review of the literature.
    Jankiewicz JJ; Hennrikus WL; Houkom JA
    Clin Orthop Relat Res; 1991 Jan; (262):205-9. PubMed ID: 1984918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.